Aktuellt
SENASTE
CMS’ NTAP recommendation is positive, and we can expect a final decision by August, followed by a good chance that the NTAP reimbursement will be effective as of October 2024. The NTAP recommendation is also good timing ahead of the US ASM conference as it allows Q-linea to engage with potential US commercial partners.
LÄS MER
